{"product_id":"krt10-antibody-sc-f1602","title":"Cytokeratin 10 Antibody","description":"\u003ch2\u003eAbout the Target\u003c\/h2\u003e\u003cp\u003eKRT10 is a target of interest in many antibody-based workflows. Keratins, also known as cytokeratins, are intermediate filament proteins predominantly found in epithelial cells. These proteins form heterodimers composed of an acidic keratin (type I keratins, K9-K28) and a basic keratin (type II keratins, K1-K8 and K71-K80), which then assemble into filaments. Keratin isoforms exhibit tissue- and differentiation-specific expression patterns, making them valuable as both research and clinical biomarkers. Depending on the literature source, KRT10 may also be discussed as Cytokeratin 10 and Keratin.\u003c\/p\u003e\u003cp\u003eReported cellular context includes cytoplasm, intermediate filament, and secreted, which can matter when signal is compared across treatments or changing cell states. Following KRT10 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.\u003c\/p\u003e\u003ch2\u003eResearch Context\u003c\/h2\u003e\u003cp\u003eKRT10 is commonly interpreted in the context of cancer, immunology, and cell cycle research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cytoplasm, intermediate filament, and secreted, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.\u003c\/p\u003e\u003cp\u003eConsider these angles when interpreting target-level changes:\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eapparent redistribution between cytoplasm, intermediate filament, and secreted across matched conditions\u003c\/li\u003e\n\u003cli\u003echanges associated with proliferative state, oncogenic signaling, or treatment response\u003c\/li\u003e\n\u003cli\u003econtext differences tied to immune-cell state, activation, or lineage composition\u003c\/li\u003e\n\u003cli\u003ecell-cycle linked differences in abundance, timing, or compartmental enrichment\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eVariant Considerations\u003c\/h2\u003e\u003cp\u003eIf your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for KRT10. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.\u003c\/p\u003e\u003cp\u003eStandardize sampling time, control choice, and downstream analysis thresholds so apparent differences in KRT10 reflect biology rather than handling. When interpreting KRT10, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.\u003c\/p\u003e\u003cp\u003eFor multi-run studies, a shared reference condition can keep KRT10 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.\u003c\/p\u003e","brand":"Selleck Chemicals","offers":[{"title":"20 µl","offer_id":57577791586649,"sku":"F1602-20UL","price":199.0,"currency_code":"EUR","in_stock":true},{"title":"100 µl","offer_id":57577791619417,"sku":"F1602-100UL","price":489.0,"currency_code":"EUR","in_stock":true},{"title":"2 × 100 µl","offer_id":57577791652185,"sku":"F1602-2X100UL","price":729.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0923\/1011\/0553\/files\/F1602-IF.png?v=1773599926","url":"https:\/\/absource.de\/products\/krt10-antibody-sc-f1602","provider":"Absource Diagnostics","version":"1.0","type":"link"}